Who Qualifies for Testosterone Replacement Therapy?

You qualify for testosterone replacement therapy only when you have both consistently low testosterone levels on blood tests and specific, bothersome symptoms—and no major contraindications like active cancer, uncontrolled heart failure, or a desire for near-term fertility. This two-part requirement is the medical standard, as stated by the American Urological Association. The FDA approves TRT only for men with low testosterone levels in conjunction with an associated medical condition, such as testicular failure or pituitary problems, but major medical societies also support treatment for symptomatic men meeting the biochemical threshold, regardless of a classical underlying cause.

That biochemical threshold isn’t a single universal number. Different guidelines cite different cut-offs under 300 ng/dL, under 350 ng/dL, or under 12 nmol/L (about 346 ng/dL). This variability means your lab result alone doesn’t decide anything; it’s the combination of that number, your symptoms, and a thorough medical review that does. A key question is who qualifies for testosterone replacement therapy. Skipping any of those three steps is how men end up on therapy they don’t need or miss out on treatment that could help.

What follows is a breakdown of the exact medical criteria, the common symptoms that count, the absolute reasons you’d be disqualified, and the practical steps to navigate the diagnosis. We’ll also look at where the guidelines disagree, because that disagreement is often the source of confusion at the doctor’s office.

Key Takeaways

• Qualification requires both low testosterone levels and specific symptoms like low libido, unexplained fatigue, or loss of muscle mass—one without the other isn’t enough.
• Blood tests must be done correctly: drawn in the morning (before 10 AM) and, for gel users, 2-8 hours after application once steady state is reached after at least a week of use.
• Active prostate cancer, severe untreated sleep apnea, and a desire for future fertility are among the hard contraindications that will disqualify you from starting TRT.
• If your total testosterone is below 150 ng/dL with abnormal pituitary hormones, expect a referral to an endocrinologist to rule out a serious hypothalamic or pituitary disorder.
• Be prepared to stop therapy if your symptoms don’t improve after 6-12 months of treatment, even if your blood levels are in range.

The Two-Part Qualification: Symptoms + Lab Tests

The foundation is how you feel matched against a number, not a lab report. The American Urological Association states it clearly: a patient is considered testosterone deficient and a candidate for therapy only when they meet both criteria of low levels combined with symptoms or signs, which is the core of the who qualifies for testosterone replacement therapy question. The challenge is that the symptoms are notoriously non-specific.

Common mistake: Chasing a TRT prescription based on a single borderline lab value without clear, documented symptoms. You might get a prescription, but you’re unlikely to see meaningful improvement, and you’ll be managing side effects for no benefit.

So, what symptoms actually count? They generally fall into three buckets: sexual, physical, and psychological. A strong case for TRT usually involves symptoms from at least two of these categories.

• Sexual Symptoms: Diminished libido (low sex drive) is the most specific. Erectile dysfunction can be related, but it has many other causes (vascular, neurological, psychological).
• Physical Symptoms: Unexplained fatigue that sleep doesn’t fix. Loss of muscle mass and strength despite regular activity. Increased body fat, particularly around the abdomen. Reduced bone mineral density (osteopenia).
• Psychological Symptoms: Depressed mood, irritability, or lack of motivation (“low drive”). Poor concentration and memory lapses.

Your doctor should use a validated questionnaire, like the ADAM (Androgen Deficiency in the Aging Male) or AMS (Aging Males’ Symptoms) scale, to document these systematically. This isn’t about checking boxes; it’s about establishing a baseline so you can both tell if treatment is actually working six months down the line.

Navigating the Blood Test Maze

This is where the rubber meets the road, and where technical details matter. You need more than just a “testosterone” test.

What to Test (The Minimum Panel):

1. Total Testosterone: The standard starting point. It measures all testosterone in your blood, both bound and free.
2. Free Testosterone: This measures the hormone that’s actually available to your tissues. It’s crucial if you have conditions that alter sex hormone-binding globulin (SHBG), like obesity or type 2 diabetes.
3. LH (Luteinizing Hormone) & FSH (Follicle-Stimulating Hormone): These pituitary hormones tell you why your testosterone is low. Low T with low/normal LH points to a pituitary/hypothalamic issue (secondary hypogonadism). Low T with high LH points to a testicular problem (primary hypogonadism).

Timing is Everything (The Part Nobody Mentions):

Your testosterone level follows a daily rhythm, peaking in the early morning. * For diagnosis: Blood must be drawn in the morning. An afternoon level can be significantly lower and doesn’t reflect your true peak.

• For monitoring on gels: Check levels 2-8 hours after application, and only after at least one week of consistent daily use to reach a steady state.
• For monitoring on injections: Check levels midway between injections (e.g., day 3 or 4 for a weekly shot) to avoid the peak and trough, aiming for that mid-normal range.

The Number Game: Why Guidelines Disagree

Don’t panic if your result is 320 ng/dL and you read online that the cutoff is 300. Different reputable bodies use different thresholds.

Guideline Source	Diagnostic Threshold (Total Testosterone)	Context
Alabama Medicaid	< 300 ng/dL	A payer guideline, often used for insurance approval.
Lisbon 2018 Consultation	< 350 ng/dL	An international sexual medicine consensus.
British Society for Sexual Medicine (BSSM)	< 12 nmol/L (≈ 346 ng/dL)	A peer-reviewed clinical guideline.

The main point? A single number doesn’t diagnose you. Your doctor will consider your symptoms, your age, and these lab values together. Levels between 250-350 ng/dL with strong symptoms often lead to a trial of therapy, while a level of 150 ng/dL is a much clearer indicator.

The FDA vs. Medical Societies: A Key Disagreement

This is a major source of confusion, and it directly impacts who qualifies for testosterone replacement therapy and can legally be prescribed it.

The U.S. Food and Drug Administration (FDA) holds a strict, label-based position. According to their official testosterone drug information, testosterone products are approved only for use in men with low testosterone levels “in conjunction with an associated medical condition.” They list examples like testicular failure from genetic problems or chemotherapy, or problems with the hypothalamus and pituitary gland.

In contrast, major medical societies like the Endocrine Society and the American Urological Association focus on the syndrome of deficiency. Their guidelines, such as the AUA testosterone deficiency guideline, recommend treatment for symptomatic men with biochemically confirmed deficiency, without requiring a specific, classical medical condition as a prerequisite.

This isn’t an academic debate. It shapes prescribing. A doctor following strict FDA labeling might decline to prescribe to a 50-year-old with symptoms and a level of 290 ng/dL without a clear “medical condition.” A doctor following society guidelines might offer a therapeutic trial. Knowing this distinction helps you understand your doctor’s perspective.

In June 2026, the FDA did update prescribing information to remove a specific limitation on use for age-related hypogonadism, signaling a shift toward the medical society view. But the core disagreement on the necessity of an underlying “disease” remains.

The Hard Stops: Who Does NOT Qualify for TRT (Contraindications)

Qualification isn’t just about what you have; it’s also about what you don’t have. The VA/DoD Clinical Practice Recommendation provides a definitive list of conditions that rule out TRT. Starting therapy with these present is dangerous.

Contraindication	Reason / Risk
Active prostate or breast cancer	Testosterone can fuel the growth of hormone-sensitive cancers.
Uncontrolled erythrocytosis (HCT >48% at start or >54% on TRT)	TRT increases red blood cell production, raising the risk of blood clots, stroke, and heart attack.
Severe, untreated obstructive sleep apnea	TRT can worsen sleep apnea, leading to severe cardiovascular strain.
PSA >4 ng/mL (or a rise >1.4 ng/mL from baseline on TRT)	Suggests possible prostate issues requiring urological evaluation first.
Desire for future fertility	TRT suppresses the body’s own sperm production (spermatogenesis).
Acute coronary syndrome, stroke, or revascularization procedure within the last 4 months	The cardiovascular system is too unstable.
Severe, uncontrolled congestive heart failure	TRT can cause fluid retention, worsening heart failure.

This is a required safety screen. A responsible provider will check for every one of these before writing a prescription. If you’re considering an online TRT clinic vs in-person doctor, verify they conduct this same thorough screening.

The Diagnostic Pathway: From Suspicion to Prescription

So how do you actually move from wondering if you qualify to holding a prescription? The process has defined steps.

1. Initial Consultation: Discuss your symptoms in detail. Use a symptom questionnaire. Your doctor will take a full medical history, focusing on the contraindications above.
2. First-Round Blood Work: This is the morning draw for total testosterone, free testosterone, LH, and FSH. It’s best to get two separate tests, ideally a few weeks apart, to confirm a consistently low level.
3. Rule Out Other Causes: Low testosterone can be a side effect, not a cause. Your doctor must check for and address reversible issues like:
   • Obesity: Excess fat converts testosterone to estrogen.
   • Poor Sleep: Chronic sleep deprivation crushes testosterone production.
   • Excessive Alcohol or Opioid Use
   • Certain Medications (e.g., corticosteroids, some antidepressants)
4. Specialist Referral (If Needed):
   • Endocrinology: Referral is recommended for very low total T (<150 ng/dL) with inappropriately normal or low LH/FSH, suggesting a pituitary problem.
   • Urology: Required if PSA is elevated (>4 ng/mL or rising >1.4 ng/mL from baseline) to rule out prostate pathology.
5. Shared Decision-Making: If you qualify and have no contraindications, you and your doctor discuss the TRT pros and cons, set realistic expectations, and choose a treatment method (gel, injection, etc.).

The entire process underscores that TRT is a long-term medical commitment requiring proper diagnosis, not a casual decision. For younger men concerned about fertility, this is the stage to discuss TRT alternatives that don’t suppress sperm production.

Treatment, Monitoring, and the 6-Month Rule

Getting a prescription is the start, not the finish. Effective management is defined by careful monitoring and a willingness to stop if it isn’t working.

Initiating Therapy: The American College of Physicians guideline suggests considering intramuscular injections (like testosterone cypionate) over transdermal gels when starting, primarily due to lower cost with similar efficacy and safety. A typical starting dose for intramuscular testosterone is 50-100 mg injected once weekly.

The Monitoring Schedule (Non-Negotiable):

• 3-6 Months After Starting: Check testosterone levels and hemoglobin/hematocrit (HCT).
• 12 Months After Starting: Repeat all the above.
• Annually Thereafter: Continue checking PSA annually. Monitoring of testosterone and hematocrit should continue per clinical guidance.

Dose Adjustment Rules:

• Adjust if: Total testosterone exceeds 900 ng/dL or hematocrit exceeds 51%.
• Stop Therapy if: Hematocrit exceeds 54%. Refer to Urology if: PSA rises >1.4 ng/mL from baseline or goes >4 ng/mL at any time.

The 6-Month Rule: The VA/DoD recommendation is blunt: set the expectation that therapy will be discontinued if symptoms do not significantly and consistently improve after 6-12 months, even if blood levels are in the target range. TRT isn’t a lifetime sentence if it’s not providing a clear benefit.

This rigorous monitoring is why consistent blood work for TRT is critical. It’s not just about optimizing dose; it’s about safety.

What medical conditions cause low testosterone?

Testosterone replacement therapy is FDA-approved only for men who have low testosterone levels due to an associated medical condition. These conditions are typically categorized as primary hypogonadism, where the testicles themselves fail, or secondary hypogonadism, where there is a problem with the brain’s signaling. Specific examples include genetic conditions or damage from chemotherapy that cause testicular failure, or disorders affecting the hypothalamus and pituitary glands in the brain. A formal diagnosis requires both documented low testosterone levels and the presence of symptoms, not just the identification of one of these underlying conditions.

What are the different forms of testosterone therapy?

Several FDA-approved delivery methods are available for testosterone replacement therapy. These include topical gels, transdermal patches, a buccal system placed against the gum, and injections. Each form has its own considerations for dosing, convenience, and cost. For example, some clinical recommendations suggest considering intramuscular injections over transdermal options when starting therapy, primarily due to lower cost with similar efficacy and safety. The choice often depends on patient preference, lifestyle, and insurance coverage, and it can be adjusted based on how well the treatment is working and tolerated.

Frequently Asked Questions

What disqualifies you from testosterone replacement therapy?

The absolute disqualifiers include active prostate or breast cancer, uncontrolled erythrocytosis (hematocrit >48% at baseline), severe untreated obstructive sleep apnea, acute coronary syndrome, stroke, or revascularization within 4 months, and a desire for future fertility, among others. A PSA level above 4 ng/mL is a contraindication to starting TRT and requires urological evaluation.

What are the signs that you need testosterone replacement therapy?

The signs are persistent and come in clusters: chronically low energy that sleep doesn’t fix, a vanished sex drive, losing muscle and gaining belly fat without lifestyle changes, and a foggy, irritable mood. One vague symptom isn’t enough; it’s the pattern that matters.

Why are doctors hesitant to prescribe TRT?

Doctors are hesitant for three main reasons: 1) The symptoms overlap with many other conditions (depression, poor sleep, aging). 2) Historical (now debated) concerns about cardiovascular and prostate cancer risks. 3) The strict FDA labeling, which creates medico-legal caution, especially if a patient doesn’t have a classic underlying medical condition.

How hard is it to get testosterone therapy?

It’s straightforward if you have clear-cut symptoms and consistently low lab values with no contraindications. It becomes difficult if your levels are borderline (e.g., 320-350 ng/dL), your symptoms are vague, or you have a complicating health issue. Navigating insurance coverage can add another layer of difficulty, as some plans strictly adhere to the lower FDA-style thresholds.

Can you get TRT if you want kids?

Not directly. TRT suppresses the hormonal signals needed for sperm production. If future fertility is a goal, you should explore alternatives first, such as clomiphene citrate or enclomiphene, which can raise natural testosterone without suppressing fertility. This is a critical discussion to have before starting.

The Bottom Line

Qualifying for TRT is a medical diagnosis built on three pillars: documented symptoms, confirmed low levels on properly-timed blood tests, and the absence of serious health risks, not about hitting a magic number. The conversation between you and your doctor should weigh the potential benefits against the commitment to long-term monitoring and the understanding that it’s a treatment for a deficiency, not an anti-aging supplement.

If your levels are borderline, invest your effort in the reversible causes first—improving sleep, managing stress, losing weight, and correcting nutrient deficiencies like vitamin D. These steps alone can significantly move your numbers. If you do start therapy, mark your calendar for that 6-12 month review. The goal isn’t just to have a prescription; it’s to feel meaningfully better. If you don’t, stopping is the correct medical decision.